VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Avantor, Inc. $AVTR

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Avantor, Inc. (NYSE:AVTR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 194,100 shares of the company’s stock, valued at approximately $1,922,000.

Several other institutional investors and hedge funds have also made changes to their positions in AVTR. Royal Bank of Canada raised its position in Avantor by 104.3% during the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after acquiring an additional 104,022 shares during the last quarter. Empowered Funds LLC increased its stake in shares of Avantor by 40.3% during the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after purchasing an additional 5,075 shares in the last quarter. Cetera Investment Advisers raised its position in shares of Avantor by 40.2% during the 2nd quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock worth $542,000 after purchasing an additional 11,543 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Avantor in the 2nd quarter valued at approximately $232,000. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Avantor by 214.9% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock valued at $1,670,000 after buying an additional 84,679 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Price Performance

Shares of NYSE:AVTR opened at $14.79 on Friday. The company has a market cap of $10.00 billion, a P/E ratio of -17.60, a P/E/G ratio of 11.23 and a beta of 0.89. The business has a fifty day simple moving average of $13.10 and a 200-day simple moving average of $10.13. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same period last year, the company earned $0.24 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities research analysts forecast that Avantor, Inc. will post 0.81 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Jefferies Financial Group raised Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price target for the company in a report on Wednesday, July 29th. TD Cowen reaffirmed a “hold” rating on shares of Avantor in a research note on Wednesday, July 15th. UBS Group began coverage on Avantor in a research report on Wednesday. They set a “neutral” rating and a $16.00 price objective for the company. Royal Bank Of Canada upped their target price on shares of Avantor from $9.00 to $14.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Finally, Wells Fargo & Company lifted their price target on shares of Avantor from $14.00 to $16.00 and gave the stock an “overweight” rating in a report on Thursday, July 30th. Two analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Avantor currently has an average rating of “Hold” and a consensus price target of $12.47.

Avantor Company Profile

Avantor, Inc (NYSE: AVTR) is a global provider of products and services used in the life sciences, healthcare and advanced technology industries. The company supports research, drug discovery, biopharmaceutical production, clinical and diagnostic activities, and other laboratory-based applications.

Its offerings include laboratory chemicals and reagents, consumables, equipment, instruments, production materials and related services. Avantor also provides supply-chain, procurement and other technical solutions designed to help customers manage laboratory and manufacturing operations.

Avantor serves customers across pharmaceutical and biopharmaceutical companies, healthcare providers, academic and government institutions, medical laboratories and industrial businesses.